Načítá se...
Interstitial Pneumonitis after Treatment with Pemetrexed for Non-small Cell Lung Cancer
Pemetrexed is approved as a first-line treatment for advanced non-squamous non-small cell lung cancer (NSCLC) with cisplatin and as a single agent for second-line treatment or for patients who show no disease progression after four cycles of platinum-based doublet induction chemotherapy as maintenan...
Uloženo v:
| Hlavní autoři: | , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Korean Cancer Association
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3629367/ https://ncbi.nlm.nih.gov/pubmed/23613674 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2013.45.1.74 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|